• br Conclusions br Disclosures br Introduction Since their

  2019-04-26

  

  Conclusions Disclosures Introduction Since their introduction, at the end of fifties, cardiovascular implantable devices (CIEDs) have widely expanded in number and in their functions [1,2]. The dramatic increase in the number of CIEDs implanted in the last decade is mainly due to the aging

• The exact location of the

  2019-04-26

  

  The exact location of the APs within the cusps is difficult to determine. The majority of studies used coronary angiography, and less commonly electroanatomical mapping. The morphology of local atrial and ventricular electrograms may be additionally used [1,2]. Mapping within the RCC typically shows

• IL IL is another potential inhibitor of OBL

  2019-04-25

  

  IL-7: IL-7 is another potential inhibitor of OBL differentiation in MM that induces RANKL production by T lymphocytes [113] and mediates MM-induced OBL inhibition by down-regulating RUNX2 transcriptional activity [93]. IL-7 levels are increased in the marrow of MM patients and that IL-7 inhibited bo

• cdc42 Additionally the expression of AMH

  2019-04-25

  

  Additionally, the expression of AMH in GCs treated with BMP15 + SB203580 was significantly decreased compared with that in GCs treated with BMP15 alone; thus, it was further demonstrated that BMP15 can up-regulate the expression of AMH by activating the p38 MAPK signaling pathway. However, the expre

• Cardiac troponin I cTnI is a well established sensitive and

  2019-04-25

  

  Cardiac troponin I (cTnI) is a well-established, sensitive, and specific marker of myocardial injury. However, evidence indicates that unrecognized myocardial injury may be occurring with certain conditions such as sepsis without acute coronary ischemic event, which demonstrate elevated cTnI levels.

• Clinical symptoms consist of the pacemaker

  2019-04-25

  

  Clinical symptoms consist of the pacemaker syndrome, including palpitations and hemodynamic instability, as in our case. The definitive management of RNRVAS requires sufficient time for the atrial tissue to recover from the refractory period. Barold et al. reviewed several general modes that could p

• br Remote technologies The platforms available for remote mo

  2019-04-25

  

  Remote technologies The platforms available for remote monitoring of ICDs differ. Wand-based (“inductive”) systems require patient-driven downloads relayed via telephone connections to tracking facilities [4,5]. These are becoming obsolete. This is because they demand coordination with a device c

• The patient had an implanted Medtronic

  2019-04-25

  

  The patient had an implanted Medtronic SECURA DR device (atrial lead: Medtronic 6940/52cm, ventricular lead: Medtronic 6945/65cm). The MRI machine used was a GE Signa HDx 1.5-Tesla system. Before performing MRI, we referred to the European position statement on MRI in patients with CIEDs [3]. Becaus

• br Conclusions Implantable monitoring devices have become hi

  2019-04-25

  

  Conclusions Implantable monitoring devices have become highly useful diagnostic tools for AT/AF [32]. However, the accuracy of the obtained diagnostic information is influenced by several factors, including the presence of non-AT/AF events, such as RNRVAS or PMT, caused by VA conduction or by sub

• The presence of an inflammatory infiltrate is associated

  2019-04-25

  

  The presence of an inflammatory infiltrate is associated with poor prognosis in a number of malignancies, including those with a predilection for metastasis to bone. CAFs are capable of promoting, and maintaining an inflammatory environment by recruiting immune cells; in particular monocyte/macropha

• The miR signature of exosomes isolated from

  2019-04-25

  

  The miR signature of exosomes isolated from bulk prostate cancer crm1 (Fig. 1A, blue cells) and from their cancer stem cell compartment (Fig. 1A, green cells), display high levels of miR-21, miR-30 and miR-218 [23] (Fig. 1A, blue arrow). miR-21 and miR-30 have been identified as key regulators of o

• pkg inhibitor br Future perspectives Identification of LOX a

  2019-04-25

  

  Future perspectives Identification of LOX as a modulator of the ECM to form pre-metastatic niches and subsequently bone metastasis arose as we were investigating the hypoxia tumour secretome using existing patient cohort data and cutting edge proteomics. Although condoned by some researchers as “

• pgc-1α inhibitor The ability of tumors to

  2019-04-25

  

  The ability of tumors to progress to more malignant phenotypes depends on tumor microenvironment. Blood capillaries, made up of endothelial cells, are usually static under physiological conditions but are induced to proliferate by direct exposure to angiogenic factors, for instance, vascular endothe

• br Autophagy and lipid metabolism LD

  2019-04-25

  

  Autophagy and lipid metabolism LD formation is an indispensable step in lipid metabolism. The Atg8/LC3 conjugation system is essential for autophagosome membrane formation. However, some evidence suggests that Atg8/LC3 conjugation is also involved in LD formation. Indeed, LD formation is suppress

• Numbers studies also showed that the

  2019-04-24

  

  Numbers studies also showed that the MSCs have the capacity to differentiate into multiple mesenchymal tissues both in vitro and in vivo, including osteoblast [25,34], condrocyte [35,36], adipocyte [37,38], tendon [39,40], skeletal muscle cells [39], cardiomyocyte [41,42] and hematopoietic supportin

15686 records 1014/1046 page Previous Next First page 上5页 10111012101310141015 下5页 Last page